Preventa

Preventa Medical is a Hungarian biotechnology company specializing in the research and development of deuterium-depleted water (DDW) for therapeutic applications in oncology and metabolic diseases. Founded in 1992 by Dr. Gábor Somlyai, the company operates as the manufacturing and commercial arm of HYD LLC for Cancer Research and Drug Development. Preventa Medical's core technology centers on the biological significance of the deuterium/hydrogen ratio in cellular signaling and its role in regulating cell growth. The company has conducted several Phase 2 clinical trials investigating DDW as a complementary treatment for various cancers, including prostate, breast, and lung cancer, as well as for metabolic disorders like diabetes. Preventa Medical markets a range of deuterium-depleted drinking water products under the Preventa® brand and is a pioneer in the field of submolecular medicine.